Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Interim Management Statement

7 Feb 2013 07:00

RNS Number : 3184X
Carclo plc
07 February 2013
 



7 February 2013

Carclo plc

("Carclo" or "the group")

 

Interim Management Statement

 

The board is pleased to report that the group is benefitting from a better second half trading performance, as expected.

 

In Technical Plastics, demand from a number of customers weakened in December and was slow to recover in January. Schedules have now returned to normal and February has started well. In LED Technologies, Wipac's supercar lighting business has enjoyed a solid start to its fourth quarter and the Precision Engineering division continues to perform well.

 

On 20 December 2012 we announced that volume production of touch sensors based on Conductive Inkjet Technology's ("CIT's") Fine Line Technology had commenced and that shipments of touch sensors had exceeded the minimum volume threshold specified in our agreement with Atmel Corporation ("Atmel"). There has been a delay in the Atmel managed downstream supply chain associated with the differing manufacturing requirements between ITO and XSense™ touch sensors. These manufacturing issues have now been largely resolved and all parties are confident that the production ramp-up will commence shortly. The US$10.0 million prepayment has been triggered but will not be received until full-scale production resumes and Atmel has invoiced its customer.

 

Validation of the Atmel US XSense™ facility is imminent but not yet complete, and this will reduce CIT film sales in the present quarter relative to our previous expectations. Commercially, Atmel report continuing high interest in XSense™ with a further design nomination confirmed and a promising pipeline of projects. Plans are well advanced at Atmel for further increases in manufacturing capacity in the second half of 2013.

 

We remain excited about the prospects for XSense™ and CIT especially in the next financial year and beyond.The group's financial position continues to be strong and will benefit further from the receipt of the US$10.0 million prepayment in due course.

 

As previously announced, Ian Williamson retires as Chief Executive on 27 March 2013 and Chris Malley will become Chief Executive on this date. Ian will continue to support Chris in a consultancy role concentrating on the technical and commercial development of Carclo Diagnostic Solutions.

 

- ENDS -

 

 

Enquiries:

Carclo plc

01924 268040

Ian Williamson, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat / Robert Cook

 

 

Notes to editors

 

·; Carclo plc is a technology led plastics group. It is a public company whose shares are quoted on the London Stock Exchange.

 

·; Approximately three fifths of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

·; Approximately two fifths of sales are derived from the supply of specialised precision products to the premium automotive and aerospace industries. Carclo is a leader in the development of high power LED lighting for supercars.

 

·; Carclo's strategy is to develop new technologies and products to drive future growth. Its investment in Conductive Inkjet Technology is at the heart of the newly emerging market for very low cost printed electronics.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGUQPPUPWGBQ
Date   Source Headline
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company
6th Oct 20221:05 pmRNSAppointment of Chief Executive Officer
16th Sep 20223:16 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSTripartite Financing Agreement Secured
2nd Sep 202212:51 pmRNSHolding(s) in Company - Correction
2nd Sep 202210:37 amRNSHolding(s) in Company
1st Sep 20223:48 pmRNSHolding(s) in Company
1st Sep 20223:20 pmRNSResults of Annual General Meeting
15th Aug 20227:00 amRNSChange of Financial Adviser and Corporate Broker
4th Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 202211:10 amRNS2022 Annual Report and Notice of AGM
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:56 pmRNSHolding(s) in Company
30th Jun 20227:20 amRNSNotice of Investor Presentation
30th Jun 20227:00 amRNSFinal Results
28th Jun 20227:00 amRNSNotice of Preliminary Results
7th Jun 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSFull Year Trading Update
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Jan 20224:41 pmRNSSecond Price Monitoring Extn
21st Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSDirector/PDMR Shareholding
30th Dec 20214:42 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20212:57 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSHalf Year Results
5th Nov 20217:00 amRNSNotice of Interim Results & Investor Presentation
2nd Sep 20213:08 pmRNSResults of Annual General Meeting
2nd Sep 20217:00 amRNSAGM Trading Update
6th Aug 20217:00 amRNSDirector/PDMR Shareholding
26th Jul 20212:47 pmRNS2021 Annual Report & Notice of AGM
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
30th Jun 20219:29 amRNSNotice of Investor Presentation
30th Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21
25th Jun 20217:00 amRNSNotice of Preliminary Results
7th May 20214:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.